Comments
Loading...

Fate Therapeutics

FATENASDAQ
Logo brought to you by Benzinga Data
$1.34
0.021.52%
At close: -
$1.36
0.021.49%
After Hours: 7:21 PM EDT

Fate Therapeutics (NASDAQ:FATE) Stock, Earnings Estimates, EPS, And Revenue

Fate Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Feb 24
EPS Estimate
$-0.430
Quarterly Revenue Estimate
$1.57M
Annual Revenue
(as of Sep 30)
$13.45M

Analyze the earnings history of Fate Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Fate Therapeutics (FATE) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-12$-0.40$-0.424.76 %
Q22024-08-13$-0.33$-0.4729.8 %
Q12024-05-09$-0.47$-0.494.08 %
Q42024-02-26$-0.45$-0.5213.5 %

Fate Therapeutics (FATE) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32024-11-12$3.07M$1.33M132.0 %
Q22024-08-13$6.77M$1.41M380.3 %
Q12024-05-09$1.93M$1.11M73.4 %
Q42024-02-26$1.68M$1.59M5.41 %

FAQ

Q

When is Fate Therapeutics (NASDAQ:FATE) reporting earnings?

A

Fate Therapeutics (FATE) is scheduled to report earnings on February 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Fate Therapeutics (NASDAQ:FATE)?

A

The Actual EPS was $-0.40, which beat the estimate of $-0.42.

Q

What were Fate Therapeutics’s (NASDAQ:FATE) revenues?

A

The Actual Revenue was $3.1M, which beat the estimate of $1.3M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch